DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Position Increased by Cerity Partners LLC

Cerity Partners LLC raised its holdings in DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Free Report) by 268.5% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 65,588 shares of the medical instruments supplier's stock after buying an additional 47,788 shares during the quarter. Cerity Partners LLC's holdings in DENTSPLY SIRONA were worth $1,294,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently modified their holdings of the company. Riverview Trust Co purchased a new stake in DENTSPLY SIRONA during the fourth quarter valued at about $26,000. MassMutual Private Wealth & Trust FSB grew its holdings in shares of DENTSPLY SIRONA by 648.4% during the 4th quarter. MassMutual Private Wealth & Trust FSB now owns 1,422 shares of the medical instruments supplier's stock worth $27,000 after purchasing an additional 1,232 shares during the period. UMB Bank n.a. increased its position in DENTSPLY SIRONA by 60.8% during the 4th quarter. UMB Bank n.a. now owns 1,492 shares of the medical instruments supplier's stock worth $28,000 after purchasing an additional 564 shares in the last quarter. Mitsubishi UFJ Asset Management Co. Ltd. increased its position in DENTSPLY SIRONA by 700.0% during the 4th quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 1,792 shares of the medical instruments supplier's stock worth $33,000 after purchasing an additional 1,568 shares in the last quarter. Finally, Signaturefd LLC raised its holdings in DENTSPLY SIRONA by 513.3% in the fourth quarter. Signaturefd LLC now owns 4,428 shares of the medical instruments supplier's stock valued at $84,000 after buying an additional 3,706 shares during the period. Institutional investors and hedge funds own 95.70% of the company's stock.

Analysts Set New Price Targets

Several research firms have recently issued reports on XRAY. Mizuho dropped their price objective on shares of DENTSPLY SIRONA from $21.00 to $18.00 and set a "neutral" rating for the company in a research report on Thursday, March 13th. Robert W. Baird lowered their price target on DENTSPLY SIRONA from $22.00 to $20.00 and set a "neutral" rating for the company in a report on Friday, February 28th. Wells Fargo & Company cut their price objective on DENTSPLY SIRONA from $20.00 to $19.00 and set an "equal weight" rating on the stock in a research report on Friday, February 28th. StockNews.com downgraded DENTSPLY SIRONA from a "buy" rating to a "hold" rating in a research report on Friday, February 28th. Finally, Barrington Research reduced their price target on DENTSPLY SIRONA from $24.00 to $20.00 and set an "outperform" rating on the stock in a research report on Friday, February 28th. Thirteen equities research analysts have rated the stock with a hold rating and two have assigned a buy rating to the stock. Based on data from MarketBeat, the company currently has an average rating of "Hold" and an average price target of $22.58.

DENTSPLY SIRONA Stock Up 4.7 %

Shares of XRAY stock traded up $0.61 during mid-day trading on Wednesday, reaching $13.63. 750,235 shares of the company were exchanged, compared to its average volume of 2,902,742. The company has a debt-to-equity ratio of 0.72, a quick ratio of 0.84 and a current ratio of 1.25. The business's 50 day simple moving average is $15.38 and its 200 day simple moving average is $18.52. The company has a market capitalization of $2.72 billion, a P/E ratio of -6.58, a P/E/G ratio of 1.80 and a beta of 0.92. DENTSPLY SIRONA Inc. has a fifty-two week low of $12.16 and a fifty-two week high of $31.00.

DENTSPLY SIRONA Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Friday, April 11th. Stockholders of record on Friday, March 28th were given a $0.16 dividend. This represents a $0.64 annualized dividend and a dividend yield of 4.70%. The ex-dividend date was Friday, March 28th. DENTSPLY SIRONA's payout ratio is currently -14.07%.

Insider Activity

In other news, Director Gregory T. Lucier acquired 15,142 shares of the stock in a transaction that occurred on Monday, March 3rd. The stock was purchased at an average cost of $16.51 per share, with a total value of $249,994.42. Following the completion of the acquisition, the director now directly owns 81,971 shares in the company, valued at $1,353,341.21. This represents a 22.66 % increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Company insiders own 0.52% of the company's stock.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.